At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study in Testing State of the Art Remote Glucose Monitoring at Diabetes Camp
In Brief
A clinical study evaluating Mini-glucagon, Remote monitoring, and 1 other intervention for Type 1 Diabetes. Completed, enrolled 57 participants across 1 site.
Detailed Summary
The incidence of low blood sugar and hypoglycemic seizures at diabetes camp has been reduced thanks to overnight blood glucose level testing. The timing of the overnight blood test is often arbitrary and it is unclear when the highest frequency of nocturnal hypoglycemic events at camp are occurring. It is also unclear what the most appropriate treatment for nocturnal hypoglycemia is: simple carbohydrates, or mini-glucagon. In this study, we will use Continuous Glucose Monitors (CGMs) that will send subject data securely to a remote computer located in the medical cottage at camp throughout the night. Study staff will monitor the computer and will intervene on low blood sugar as it occurs in real time. On half of the nights, campers will receive mini-glucagon for low blood sugar, and on the rest, they will receive standard carbohydrate treatment.
Study Details
Timeline
Interventions
Mini dose glucagon given for glucose \<70 mg/dl at a dose of 1unit/year of age
Provides real-time continuous glucose monitoring
16 grams of carbohydrate